Company Legal Name
Latest Valuation
Founded Year
Headquarter
Yazen Health AB operates a digital healthcare platform specializing in comprehensive weight loss programs that integrate modern medications with personalized lifestyle interventions under medical supervision. Founded in 2021 and headquartered in Lund, Sweden, the telehealth company differentiates itself by offering a holistic approach that combines pharmaceutical treatments with individualized coaching and behavioral support. The platform addresses the growing demand for accessible, medically-supervised weight management solutions in the expanding telehealth market. Yazen focuses on delivering measurable health outcomes through its integrated care model, positioning itself to capitalize on increasing consumer acceptance of digital healthcare services and the rising prevalence of obesity-related health concerns across European markets.
Revenue & Revenue Growth Share
Revenue
Revenue Growth
Available in most regions; subject to local regulations.
Open to non-accredited investors with KYC/AML compliance. U.S. investors must meet SEC requirements.
$10 per token, enabling fractionalized access to Pre-IPO shares.
Mandatory identity (KYC) and proof of funds checks.
Variable, applied to investment amounts.
Charged on realized profits.
Tokens may be locked for 6–12 months; resale depends on secondary market liquidity.
Prices reflect past funding rounds, not guaranteed future value.
Biotech depends on regulatory approvals; fintech faces evolving digital asset rules.
Blockchain or custodian issues could delay transfers or verification.
Changing laws may affect tradability or taxation.
